enfortumab vedotin,pembrolizumab
astellas,merck,Seagen
['pembro', 'keytruda', 'enfortumab', 'padcev', 'urothelial', 'seagen', '$mrk', 'merck', 'astellas', '$sgen']
#seagen #astellas and #merck announce results of clinical trial investigating #padcev (#enfortumabvedotinejfv) with #keytruda (#pembrolizumab) and #padcev as #monotherapy in first-line advanced #urothelialcancer #esmo22 $sgen $mrk 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.